JERSEY CITY, N.J., February 20, 2024--Organon Announces HADLIMA Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary
JERSEY CITY, N.J., February 15, 2024--Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2023
JERSEY CITY, N.J., February 01, 2024--Organon will release fourth quarter and full year 2023 financial results on February 15, 2024, and hold a webcast and conference call at 8:30 AM EST.